Guizhou Yibai Pharmaceutical Co., Ltd.

600594

CNE000001H03

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 23:00:00 30/05/2024 BST			5-day change	1st Jan Change
3.59 ^CNY	+1.13%		-3.49%	-36.91%

04-18	Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
2023	YiBai Pharma to Repurchase Up to 40 Million Yuan Shares	MT

Guizhou Yibai Pharmaceutical Co., Ltd. Announces Cash Dividend for First Half of 2020, Payable September 2, 2020

August 25, 2020

Guizhou Yibai Pharmaceutical Co., Ltd. implemented the scheme of rights and interests distribution for first half of 2020 as follows: a cash dividend of RMB 0.30 (taxes included) per A share. Record date: September 1, 2020. Ex-dividend date: September 2, 2020. Cash dividend payable date: September 2, 2020.

Latest news about Guizhou Yibai Pharmaceutical Co., Ltd.

Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-18	CI
YiBai Pharma to Repurchase Up to 40 Million Yuan Shares	11-30	MT
Guizhou Yibai Pharmaceutical Co., Ltd. announces an Equity Buyback for CNY 40 million worth of its shares.	11-29	CI
Guizhou Yibai Pharmaceutical Co., Ltd. authorizes a Buyback Plan.	11-28	CI
Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	26/10/23	CI
Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	17/08/23	CI
Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	27/04/23	CI
Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	27/04/23	CI
GuiZhou YiBai Pharma to Book 2022 Loss on Policy Changes, COVID-19	25/01/23	MT
Guizhou Yibai Pharmaceutical Completes Construction of $84.5 Million Factory	24/11/22	MT
Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	27/10/22	CI
Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	25/08/22	CI
Guizhou Yibai Traditional Chinese Medicine Formula Granules Pharmaceutical Co., Ltd. announced that it expects to receive CNY 179.8539 million in funding from Guizhou Yibai Pharmaceutical Co., Ltd., Guizhou Province Agricultural and Rural Modernization Development Equity Investment Fund Partnership	28/06/22	CI
Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22/04/22	CI
Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22/04/22	CI
Guizhou Yibai Pharmaceutical Co., Ltd. completed the acquisition of 70% stake in Deyang Cancer Hospital Co., Ltd. from Deyang Foji Hospital Management Partnership (Limited Partnership), Deyang Foming Hospital Management Partnership (Limited Partnership) and Deyang Foxiang Management Hospital Partnership (Limited Partnership)	26/11/21	CI
Guizhou Yibai Pharmaceutical Co., Ltd. signed an equity transfer agreement to acquire a 70% stake in Deyang Cancer Hospital Co., Ltd. from Deyang Foji Hospital Management Partnership (Limited Partnership), Deyang Foming Hospital Management Partnership (Limited Partnership) and Deyang Foxiang Management Hospital Partnership (Limited Partnership) for approximately CNY 340 million.	27/10/21	CI
Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	27/10/21	CI
Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	26/08/21	CI
Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	22/04/21	CI
Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020	28/10/20	CI
Guizhou Yibai Pharmaceutical Co., Ltd. Announces Cash Dividend for First Half of 2020, Payable September 2, 2020	25/08/20	CI
Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020	29/07/20	CI
Guizhou Yibai Pharmaceutical Co., Ltd. Announces Cash Dividend for 2019, Payable June 3, 2020	26/05/20	CI
Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2020	27/04/20	CI

Chart Guizhou Yibai Pharmaceutical Co., Ltd.

Duration

Period

Chart Guizhou Yibai Pharmaceutical Co., Ltd.

More charts

Company Profile

GUIZHOU YIBAI PHARMACEUTICAL CO., LTD is a China-based company, principally engaged in the production and distribution of pharmaceuticals. The Company provides prescription drugs and over the counter (OTC) products, including injections, capsules, oral liquid, granules and tablets, among others. The company's products are applied in the treatment of cancer, cardiovascular and cerebrovascular, orthopedics, digestion, gynecology, children and breathing, among others. The Company mainly conducts its businesses within domestic markets.

Sector

Pharmaceuticals

Calendar

04/06/2024 - Extraordinary Shareholders Meeting

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
GUIZHOU YIBAI PHARMACEUTICAL CO., LTD.	-36.91%	393M
ELI LILLY AND COMPANY	+40.73%	739B
NOVO NORDISK A/S	+32.83%	598B
JOHNSON & JOHNSON	-6.30%	353B
MERCK & CO., INC.	+15.15%	318B
ABBVIE INC.	+4.05%	285B
ASTRAZENECA PLC	+15.00%	240B
ROCHE HOLDING AG	-5.52%	206B
AMGEN INC.	+6.17%	164B
PFIZER, INC.	-0.45%	162B